Targeted treatment for leukemia approved on NHS in England
The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukemia (AML) on the NHS in England. The National Institute for Health and Care Excellence (NICE) overturned their initial rejection of ...
Jul 17, 2020
0
2